Neoplasms Trials in Dallas, United States
Conditions / Neoplasms / Dallas, United States
Neoplasms has been the subject of sustained clinical investigation across multiple research sites.
49 total trials for this combination
Showing top 10 of 49 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03037385 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT04673942 | A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors | RECRUITING | PHASE2 |
| NCT03435796 | Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | RECRUITING | PHASE2/PHASE3 |
| NCT01964430 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the Apact Study) | COMPLETED | PHASE3 |
| NCT04644315 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | TERMINATED | PHASE2 |
| NCT03981796 | A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04711109 | Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02889978 | The Circulating Cell-free Genome Atlas Study | UNKNOWN | — |
| NCT05103358 | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06785636 | Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 | RECRUITING | — |